World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
30698
World Ranking
14486
National Ranking
7328

Overview

Jeffrey S. Berger is affiliated with New York University in the United States. Their primary field of study is Medicine, with a strong focus on Cardiology and Cardiovascular Medicine. Other significant subfields of study include Surgery, Immunology, Infectious Diseases, and Internal Medicine.

The research topics Jeffrey S. Berger has concentrated on cover various aspects of cardiovascular and related health conditions. These include Antiplatelet Therapy and Cardiovascular Diseases, COVID-19 Clinical Research Studies, Venous Thromboembolism Diagnosis and Management, Peripheral Artery Disease Management, Cardiac, Anesthesia and Surgical Outcomes, Lipoproteins and Cardiovascular Health, and Coronary Interventions and Diagnostics.

Jeffrey S. Berger's recent published papers include:

  • Initial Invasive or Conservative Strategy for Stable Coronary Disease, 2020, New England Journal of Medicine
  • Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19, 2020, New England Journal of Medicine
  • Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, 2021, New England Journal of Medicine
  • Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System, 2020, JAMA
  • Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19., 2021, Bristol Research (University of Bristol)

Frequent collaborators of Jeffrey S. Berger include Judith S. Hochman, Harmony R. Reynolds, Tessa J. Barrett, Nathaniel R. Smilowitz, and Jonathan Newman.

Their work has been published extensively in several prominent medical journals, with the most frequent publication venues being Circulation, Arteriosclerosis Thrombosis and Vascular Biology, Journal of the American College of Cardiology, Journal of the American Heart Association, and Research and Practice in Thrombosis and Haemostasis.

Best Publications

  • Initial invasive or conservative strategy for stable coronary disease.

    David J. Maron;Judith S. Hochman;Harmony R. Reynolds;Sripal Bangalore

  • Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis

    S. G. Chu;R. C. Becker;P. B. Berger;D. L. Bhatt

  • Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19.

    Harmony R. Reynolds;Samrachana Adhikari;Claudia Pulgarin;Andrea B. Troxel

  • Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-analysis of Randomized Controlled Trials

    Jeffrey S. Berger;Maria C. Roncaglioni;Fausto Avanzini;Ierta Pangrazzi

  • Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.

    Seda Bilaloglu;Yin Aphinyanaphongs;Simon Jones;Eduardo Iturrate

  • Sex differences in mortality following acute coronary syndromes.

    Jeffrey S. Berger;Laine Elliott;Dianne Gallup;Matthew Roe

  • Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

    William R Hiatt;F Gerry R Fowkes;Gretchen Heizer;Jeffrey S Berger

  • Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative

    Annie L. Culver;Ira S. Ockene;Raji Balasubramanian;Barbara C. Olendzki

  • Mechanical Complications of Central Venous Catheters

    Lewis A. Eisen;Mangala Narasimhan;Jeffrey S. Berger;Paul H. Mayo

  • Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series.

    Amy V. Rapkiewicz;Xingchen Mai;Steven E. Carsons;Stefania Pittaluga

  • Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

    Jeffrey S. Berger;Mori J. Krantz;John M. Kittelson;William R. Hiatt

  • Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention

    Chiara Melloni;Jeffrey S. Berger;Tracy Y. Wang;Funda Gunes

  • Management of Coronary Disease in Patients with Advanced Kidney Disease

    Sripal Bangalore;David J. Maron;Sean M. O’Brien;Jerome L. Fleg

  • Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery.

    Nathaniel R. Smilowitz;Navdeep Gupta;Harish Ramakrishna;Yu Guo

  • Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects.

    Nazir Savji;Caron B. Rockman;Adam H. Skolnick;Yu Guo

  • C-reactive protein and clinical outcomes in patients with COVID-19.

    Nathaniel R Smilowitz;Dennis Kunichoff;Michael Garshick;Binita Shah

  • Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure.

    Natalia V. Solenkova;Jonathan D. Newman;Jeffrey S. Berger;George Thurston

  • Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials.

    Richard Andraws;Jeffrey S. Berger;David L. Brown

  • Screening for cardiovascular risk in asymptomatic patients.

    Jeffrey S. Berger;Jeffrey S. Berger;Courtney O. Jordan;Donald Lloyd-Jones;Roger S. Blumenthal

  • Ticagrelor Versus Clopidogrel in Symptomatic Peripheral Artery Disease

    W.R. Hiatt;F.G. Fowkes;G. Heizer;J.S. Berger

Frequent Co-Authors

Judith S. Hochman
Judith S. Hochman New York University
William R. Hiatt
William R. Hiatt University of Colorado Denver
Manesh R. Patel
Manesh R. Patel Duke University
Edward A. Fisher
Edward A. Fisher New York University
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Sripal Bangalore
Sripal Bangalore New York University
James G. Krueger
James G. Krueger Rockefeller University
Christian Torp-Pedersen
Christian Torp-Pedersen Aalborg University
Richard C. Becker
Richard C. Becker University of Cincinnati
Steven R. Steinhubl
Steven R. Steinhubl Scripps Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens doors to a variety of related degrees and flexible online programs. For those seeking a swift path into advanced nursing—even without a nursing background—considering non nursing bachelor's to msn online programs can be an effective option. These direct entry tracks allow students to earn a Master of Science in Nursing and enter advanced practice roles more efficiently.

If your goal is to start your nursing journey quickly, online adn programs are designed for accessibility and can lead to an RN license in as little as two years. Furthermore, some absn programs that don't require teas exams can streamline the admissions process, removing barriers for busy applicants.

For those interested in administrative roles, online medical coding classes with financial aid can be a cost-effective way to enter the growing field of medical billing and coding. Exploring these alternative career pathways can broaden your options and help you find the best fit within the healthcare sector.

Best Scientists Citing Jeffrey S. Berger

Trending Scientists

Recently Published Articles